PGNX - Progenics Pharmaceuticals Inc.
Previous close
4.1
0 0%
Share volume: 0
Last Updated: Fri 19 Jun 2020 06:00:00 AM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$4.10
0.00
0.00%
Summary score
21%
Profitability
8%
Dept financing
17%
Liquidity
23%
Performance
34%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.21%
Return on assets
-7.3%
Return on sales
-211.32%
Return on invested capital
-97.42%
Total debt ratio
52%
Debt ratio change over timeo
-2.49%
Current Ratio
6.25%
Quick Ratio
0%
Cash Position Ratio
5.78%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-34.88%
Return on assets
-12.85%
Return on sales
-211.32%
Return on invested capital
-48.54%
Total debt ratio
60.08%
Debt ratio change over timeo
-2.23%
Current Ratio
3.26%
Quick Ratio
0%
Cash Position Ratio
2.56%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-54.88%
Return on assets
-16.46%
Return on sales
-259.06%
Return on invested capital
-43.41%
Total debt ratio
68.87%
Debt ratio change over time
-3.32%
Current Ratio
2.12%
Quick Ratio
0%
Cash Position Ratio
1.55%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-34.43%
Return on assets
-75.11%
Return on sales
330.5%
Return on invested capital
64.29%
Total debt ratio
-249.19%
Debt ratio change over time
-2.49%
Current Ratio
-17.67%
Quick Ratio
0%
Cash Position Ratio
-16.5%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PGNX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -19.21% | -40.8% | -11.36% | -12.25% |
| Return on assets | -7.3% | -19.78% | -8.97% | -9.49% |
| Return on sales | -211.32% | -5539.23% | 0% | -349.39% |
| Return on invested capital | -97.42% | 342.85% | -123.82% | -117.39% |
| Profitability | 25% | 25% | 50% | 0% |
| Total debt ratio | 52% | 121.38% | 25.26% | 26.21% |
| Debt ratio change over time | -2.49% | -0.12% | -1.11% | -1.45% |
| Dept financing | 11% | 50% | 5% | 5% |
| Current Ratio | 3.26% | 8.43% | 6.41% | 5.11% |
| Quick Ratio | 0% | 0% | 0% | 4.79% |
| Cash Position Ratio | 2.56% | 8.13% | 3.15% | 1.72% |
| Liquididy | 37% | 48% | 25% | 59% |
| Short-term ratios | PGNX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -34.88% | -135.01% | -20.23% | -17.62% |
| Return on assets | -12.85% | -15.63% | -15.18% | -9.31% |
| Return on sales | -211.32% | 0% | 0% | -398.97% |
| Return on invested capital | -48.54% | 435.95% | 248.95% | -45.1% |
| Profitability | 0% | 25% | 39% | 50% |
| Total debt ratio | 60.08% | 74.66% | 29.16% | 48.64% |
| Debt ratio change over time | -2.23% | -0.82% | -1.48% | -2.29% |
| Dept financing | 20% | 50% | 10% | 16% |
| Current Ratio | 3.26% | 8.43% | 6.41% | 5.11% |
| Quick Ratio | 0% | 0% | 0% | 4.79% |
| Cash Position Ratio | 2.56% | 8.13% | 3.15% | 1.72% |
| Liquididy | 18% | 50% | 29% | 45% |